NO20000293L - Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner - Google Patents
Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepinerInfo
- Publication number
- NO20000293L NO20000293L NO20000293A NO20000293A NO20000293L NO 20000293 L NO20000293 L NO 20000293L NO 20000293 A NO20000293 A NO 20000293A NO 20000293 A NO20000293 A NO 20000293A NO 20000293 L NO20000293 L NO 20000293L
- Authority
- NO
- Norway
- Prior art keywords
- local anesthetic
- methods
- headaches
- muscular
- patient
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 206010019233 Headaches Diseases 0.000 title abstract 4
- 230000002490 cerebral effect Effects 0.000 title abstract 4
- 231100000869 headache Toxicity 0.000 title abstract 4
- 208000017376 neurovascular disease Diseases 0.000 title abstract 4
- 230000003387 muscular Effects 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 3
- 208000006561 Cluster Headache Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 206010027603 Migraine headaches Diseases 0.000 abstract 1
- 206010043269 Tension headache Diseases 0.000 abstract 1
- 208000008548 Tension-Type Headache Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000004118 muscle contraction Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000007910 systemic administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89719297A | 1997-07-21 | 1997-07-21 | |
| US7284598P | 1998-01-28 | 1998-01-28 | |
| US8455998P | 1998-05-06 | 1998-05-06 | |
| PCT/US1998/014870 WO1999003473A1 (en) | 1997-07-21 | 1998-07-17 | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000293D0 NO20000293D0 (no) | 2000-01-20 |
| NO20000293L true NO20000293L (no) | 2000-03-20 |
Family
ID=27372174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000293A NO20000293L (no) | 1997-07-21 | 2000-01-20 | Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0999839B1 (https=) |
| JP (1) | JP4521117B2 (https=) |
| KR (1) | KR20010022041A (https=) |
| CN (1) | CN1267219A (https=) |
| AR (1) | AR013240A1 (https=) |
| AT (1) | ATE269702T1 (https=) |
| AU (1) | AU8574398A (https=) |
| BR (1) | BR9810773A (https=) |
| CA (1) | CA2297097C (https=) |
| DE (1) | DE69824730T2 (https=) |
| EE (1) | EE200000050A (https=) |
| HU (1) | HUP0003953A3 (https=) |
| ID (1) | ID24903A (https=) |
| IL (2) | IL134087A0 (https=) |
| IS (1) | IS5349A (https=) |
| NO (1) | NO20000293L (https=) |
| PL (1) | PL338176A1 (https=) |
| SK (1) | SK187899A3 (https=) |
| TR (1) | TR200000149T2 (https=) |
| WO (1) | WO1999003473A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704349D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
| JP4632499B2 (ja) * | 1999-08-26 | 2011-02-16 | 武田薬品工業株式会社 | 鼻粘膜付着マトリックス |
| AU2100901A (en) * | 1999-12-15 | 2001-06-25 | Bruce H. Levin | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| GB9930083D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| US7117033B2 (en) | 2000-05-08 | 2006-10-03 | Brainsgate, Ltd. | Stimulation for acute conditions |
| AU5662001A (en) | 2000-05-08 | 2001-11-20 | Brainsgate Ltd. | Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow |
| US7640062B2 (en) | 2000-05-08 | 2009-12-29 | Brainsgate Ltd. | Methods and systems for management of alzheimer's disease |
| US7146209B2 (en) | 2000-05-08 | 2006-12-05 | Brainsgate, Ltd. | Stimulation for treating eye pathologies |
| US6853858B2 (en) | 2000-05-08 | 2005-02-08 | Brainsgate, Ltd. | Administration of anti-inflammatory drugs into the central nervous system |
| WO2004043218A2 (en) | 2002-11-14 | 2004-05-27 | Brainsgate Ltd. | Surgical tools and techniques for stimulation |
| US7561919B2 (en) | 2002-11-14 | 2009-07-14 | Brainsgate Ltd. | SPG stimulation via the greater palatine canal |
| WO2005062829A2 (en) | 2003-12-19 | 2005-07-14 | Advanced Bionics Corporation | Skull-mounted electrical stimulation system and method for treating patients |
| US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
| US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
| US8055347B2 (en) | 2005-08-19 | 2011-11-08 | Brainsgate Ltd. | Stimulation for treating brain events and other conditions |
| US7592371B2 (en) | 2004-08-18 | 2009-09-22 | Medrx Co., Ltd. | External preparation |
| AU2009274137B2 (en) * | 2008-07-21 | 2013-10-31 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| DE102008037682A1 (de) | 2008-08-14 | 2010-04-08 | Strackharn, Klaus, Dr.med. | Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen |
| US9889109B2 (en) | 2012-09-28 | 2018-02-13 | St. Renatus, Llc | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines |
| CN103432378A (zh) * | 2013-08-15 | 2013-12-11 | 吕清华 | 一种治疗神经血管性头痛的中药 |
| US9675796B2 (en) | 2013-11-10 | 2017-06-13 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| US10271907B2 (en) | 2015-05-13 | 2019-04-30 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
| CN113573705A (zh) * | 2018-12-19 | 2021-10-29 | 诺迪克控股公司 | 鼻内利多卡因的治疗组合物 |
| WO2020152212A1 (en) * | 2019-01-22 | 2020-07-30 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions |
| GB2628149A (en) * | 2023-03-16 | 2024-09-18 | Lee Nathaniel Wurie | Nasal spray for performing sphenopalatine ganglion block |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321061D0 (en) * | 1993-10-13 | 1993-12-01 | Chiroscience Ltd | Analgestic agent and its use |
| DE19524691A1 (de) * | 1995-07-06 | 1997-01-09 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen |
| DE19526019A1 (de) * | 1995-07-17 | 1997-01-23 | Liedtke Pharmed Gmbh | Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen |
| BE1009851A3 (fr) * | 1996-01-11 | 1997-10-07 | Thiebauld Charles Marie | Composition pharmaceutique pour le traitement des cephalees et son utilisation. |
| GB2315673A (en) * | 1996-08-01 | 1998-02-11 | Merck & Co Inc | Treatment of migraine |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| GB9704349D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
-
1998
- 1998-07-17 CN CN98808214A patent/CN1267219A/zh active Pending
- 1998-07-17 EP EP98936893A patent/EP0999839B1/en not_active Expired - Lifetime
- 1998-07-17 HU HU0003953A patent/HUP0003953A3/hu unknown
- 1998-07-17 IL IL13408798A patent/IL134087A0/xx active IP Right Grant
- 1998-07-17 AT AT98936893T patent/ATE269702T1/de not_active IP Right Cessation
- 1998-07-17 AU AU85743/98A patent/AU8574398A/en not_active Abandoned
- 1998-07-17 KR KR1020007000610A patent/KR20010022041A/ko not_active Withdrawn
- 1998-07-17 PL PL98338176A patent/PL338176A1/xx unknown
- 1998-07-17 DE DE69824730T patent/DE69824730T2/de not_active Expired - Lifetime
- 1998-07-17 TR TR2000/00149T patent/TR200000149T2/xx unknown
- 1998-07-17 JP JP2000502772A patent/JP4521117B2/ja not_active Expired - Fee Related
- 1998-07-17 WO PCT/US1998/014870 patent/WO1999003473A1/en not_active Ceased
- 1998-07-17 EE EEP200000050A patent/EE200000050A/xx unknown
- 1998-07-17 BR BR9810773-9A patent/BR9810773A/pt not_active IP Right Cessation
- 1998-07-17 CA CA002297097A patent/CA2297097C/en not_active Expired - Lifetime
- 1998-07-17 ID IDW20000123D patent/ID24903A/id unknown
- 1998-07-17 SK SK1878-99A patent/SK187899A3/sk unknown
- 1998-07-21 AR ARP980103565A patent/AR013240A1/es unknown
-
2000
- 2000-01-17 IL IL134087A patent/IL134087A/en not_active IP Right Cessation
- 2000-01-18 IS IS5349A patent/IS5349A/is unknown
- 2000-01-20 NO NO20000293A patent/NO20000293L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8574398A (en) | 1999-02-10 |
| HUP0003953A3 (en) | 2002-02-28 |
| ID24903A (id) | 2000-08-31 |
| DE69824730D1 (de) | 2004-07-29 |
| BR9810773A (pt) | 2000-09-19 |
| CA2297097C (en) | 2009-04-07 |
| KR20010022041A (ko) | 2001-03-15 |
| PL338176A1 (en) | 2000-10-09 |
| DE69824730T2 (de) | 2005-07-14 |
| TR200000149T2 (tr) | 2000-05-22 |
| IL134087A (en) | 2006-10-31 |
| CA2297097A1 (en) | 1999-01-28 |
| EE200000050A (et) | 2000-10-16 |
| EP0999839B1 (en) | 2004-06-23 |
| EP0999839A1 (en) | 2000-05-17 |
| JP4521117B2 (ja) | 2010-08-11 |
| CN1267219A (zh) | 2000-09-20 |
| HUP0003953A1 (hu) | 2002-01-28 |
| NO20000293D0 (no) | 2000-01-20 |
| JP2001513483A (ja) | 2001-09-04 |
| SK187899A3 (en) | 2000-12-11 |
| IS5349A (is) | 2000-01-18 |
| WO1999003473A1 (en) | 1999-01-28 |
| ATE269702T1 (de) | 2004-07-15 |
| IL134087A0 (en) | 2001-04-30 |
| AR013240A1 (es) | 2000-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000293L (no) | Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner | |
| WO2001062236A3 (en) | New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent | |
| NO980592L (no) | Nye opioidpeptider | |
| NO20015931L (no) | Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin | |
| NO20043531L (no) | Indazolforbindelser som er nyttige som proteinkinaseinhibitorer | |
| DK1076657T3 (da) | Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling | |
| BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
| BR9917038A (pt) | Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias | |
| EP0919234A3 (en) | Potentiation of pharmaceuticals by moxonidine | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| TR200001279T2 (tr) | Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler. | |
| NO20056252L (no) | Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser | |
| BR0213040A (pt) | Composto, processo para preparar um composto, e, método de tratar doenças | |
| BR9806157A (pt) | Composições farmacêuticas de descarboetoxiloratadina anidras, não higroscópicas e sem lactose | |
| NO954878L (no) | Pyrrolderivater | |
| WO2001043733A3 (en) | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | |
| ES2136252T3 (es) | Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa. | |
| EE04491B1 (et) | (+)-nortsisapriidi kasutamine | |
| NO992062L (no) | Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel | |
| SE9603725D0 (sv) | New teatment | |
| MX9701820A (es) | Compuestos de pirazolo [3,4-g] quinoxalina que inhiben proteina tirosina quinasa receptora de pdgf. | |
| EP1064966A3 (en) | Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine | |
| HK1051485A1 (zh) | 增生性疾病的治療 | |
| WO2001030331A3 (en) | Therapeutic compositions including protein kinase c inhibitors | |
| MXPA02010184A (es) | Formulaciones topicas para el suministro transdermico de niacina y metodos para tratar hiperlipidemia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |